Table 4. Cox proportional hazard model for prognosis of HD patients at a four-year follow-up.
Univariatea | Multivariatea | |||||||
Factorb | 95% CIc | 95% CI | ||||||
HRd | Lower | Upper | p Value | HR | Lower | Upper | p Value | |
ELISA - Vitamin D binding protein, 10 mg/L | 0.895 | 0.817 | 0.980 | 0.013* | 0.843 | 0.756 | 0.951 | 0.006 |
Age, year | 1.045 | 1.003 | 1.089 | 0.037* | 1.048 | 1.005 | 1.092 | 0.027 |
Male gender, % | 1.445 | 0.538 | 3.883 | 0.465 | ||||
Dialysis vintage, years | 0.900 | 0.800 | 1.013 | 0.080* | ||||
Body weight, Kg | 1.046 | 0.986 | 1.109 | 0.137 | ||||
Height, cm | 1.048 | 0.987 | 1.113 | 0.129 | ||||
Body mass index, kg/m2 | 1.040 | 0.889 | 1.217 | 0.620 | ||||
Systolic blood pressure, mmHg | 1.011 | 0.978 | 1.045 | 0.514 | ||||
Diastolic blood pressure, mmHg | 1.008 | 0.942 | 1.079 | 0.823 | ||||
Smoking index | 1.167 | 0.795 | 1.712 | 0.430 | ||||
Medications | ||||||||
ACE inhibitor/ARB, % | 1.132 | 0.403 | 3.183 | 0.936 | ||||
Vitamin D3, % | 1.079 | 0.347 | 3.353 | 0.895 | ||||
Laboratory data | ||||||||
Leukocyte count, ×103/µL | 1.000 | 0.999 | 1.000 | 0.117 | ||||
Hemoglobin, g/dL | 1.011 | 0.684 | 1.495 | 0.954 | ||||
Hematocrit, % | 1.012 | 0.887 | 1.154 | 0.863 | ||||
Albumin, g/dL | 0.162 | 0.020 | 1.328 | 0.090* | 0.064 | 0.008 | 0.574 | 0.012 |
Blood urea nitrogen, mg/dL | 1.005 | 0.973 | 1.038 | 0.752 | ||||
Creatinine, mg/dL | 1.134 | 0.648 | 1.983 | 0.660 | ||||
Sodium, meq/dL | 1.023 | 0.835 | 1.254 | 0.826 | ||||
Potassium, meq/dL | 1.464 | 0.721 | 2.973 | 0.291 | ||||
Fasting blood sugar, mg/dL | 1.016 | 0.990 | 1.042 | 0.226 | ||||
Total cholesterol, mg/dL | 0.998 | 0.985 | 1.012 | 0.777 | ||||
HDL-C, mg/dL | 1.001 | 0.972 | 1.032 | 0.939 | ||||
LDL-C, mg/dL | 0.992 | 0.980 | 1.004 | 0.210 | ||||
ApoB, mg/dL | 0.985 | 0.966 | 1.005 | 0.147 | ||||
Lp(a), mg/dL | 1.005 | 0.947 | 1.067 | 0.875 | ||||
Triglycerides, mg/dL | 1.001 | 0.997 | 1.005 | 0.557 | ||||
Uric acid, mg/dL | 0.821 | 0.576 | 1.170 | 0.275 | ||||
Alanine aminotransferase, U/L | 1.008 | 0.982 | 1.036 | 0.542 | ||||
γ-glutamyl transferase, U/L | 0.999 | 0.982 | 1.017 | 0.906 | ||||
Alkaline phosphatase, U/L | 1.004 | 0.997 | 1.011 | 0.231 | ||||
Calcium, mg/dL | 0.591 | 0.332 | 1.052 | 0.074* | ||||
Phosphate, mg/dL | 1.162 | 0.789 | 1.713 | 0.447 | ||||
Calcium × Phosphate product | 1.003 | 0.964 | 1.044 | 0.876 | ||||
Intact-parathyroid hormone, pg/mL | 1.001 | 1.000 | 1.003 | 0.157 | ||||
25(OH) Vitamin D, ng/mL | 1.033 | 0.973 | 1.096 | 0.289 | ||||
Kt/V | 0.026 | 0.002 | 0.545 | 0.124 |
Values are expressed as mean ± SD or percent.
ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker.
CI, confidence interval.
HR, hazard ratio.
p<0.10 in univariate Cox regression analysis.